FDA
-
-
-
-
-
-
-
Leerink Upgrades Gossamer Bio Inc. (GOSS) to Outperform
-
-
-
-
-
-
-
Cantor Fitzgerald Downgrades Gossamer Bio Inc. (GOSS) to Neutral
-
-
-
-
-
-
-
Gossamer Bio gets option to acquire Respira Therapeutics
-
-
-
-
-
-
-
Gossamer Bio Announces Appointment of Steven D. Nathan, M.D., and Skye Drynan to its Board of Directors
-
-
-
-
-
-
-
Quantum Leap Healthcare Collaborative Discontinues Testing of Aerpio Pharmaceutical's Razuprotafib in I-SPY COVID Trial
-
-
-
-
-
-
-
Aerpio Pharmaceuticals, Inc. and Quantum Leap Healthcare Collaborative Announce the Selection of Razuprotafib for Evaluation in the I-SPY COVID Trial for the Treatment of Acute Respiratory Distress Sy
-
-
-
-
-
-
331,289 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

